Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002180202 | SCV002350847 | likely benign | not provided | 2025-01-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003289423 | SCV004006812 | uncertain significance | Inborn genetic diseases | 2023-03-22 | criteria provided, single submitter | clinical testing | The c.2128C>A (p.P710T) alteration is located in exon 22 (coding exon 22) of the TNNI3K gene. This alteration results from a C to A substitution at nucleotide position 2128, causing the proline (P) at amino acid position 710 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Department of Pathology and Laboratory Medicine, |
RCV005397297 | SCV006058779 | uncertain significance | Atrial conduction disease | 2022-10-26 | criteria provided, single submitter | research |